ALEXA PALEY: Open Payments
NPI 1942852199 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 106 payments from 21 companies in 2025. Trend: 2023 $1,325 · 2024 $3,362 · 2025 $2,044
Food & beverage: $1,884Education: $160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $347 |
| Janssen Biotech, Inc. | 14 | $264 |
| Novartis Pharmaceuticals Corporation | 9 | $227 |
| GENZYME CORPORATION | 10 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $159 |
| Lilly USA, LLC | 12 | $150 |
| UCB, Inc. | 6 | $103 |
| Incyte Corporation | 4 | $87 |
| Amgen Inc. | 4 | $87 |
| PFIZER INC. | 3 | $61 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, TALTZ, Bimzelx, RINVOQ, OPZELURA.
Industry payments across NE — which companies pay providers there.
